Boston Scientific develops, manufactures, and markets medical devices. Q4 earnings were reported this week providing a clear picture of 2022 annual fundamentals. The fundamentals considered are presented on the chart with brief commentary.
Technical considerations:
Price bounced off of trend line going back to 2012
Ascending triangle breakout
New ATH weekly...
R&D spending on the metaverse and other projects is eating into net income. Revenue is still impressive. People still use Facebook and Instagram. With a P/E of 8.649 nearing the bottom of a parallel channel drawn on the log scale chart, I can’t help but think there’s an options play or even a great long-term buying opportunity waiting to be had some time over...
